BioPlus Acquisition Corp.

BioPlus Acquisition Corp. (Nasdaq: BIOS) is a blank-check company that completed its initial public offering in 2021, targeting the healthcare and life sciences sector. The SPAC filed a Form 10-Q with the SEC on May 12, 2022, covering the quarterly period ended March 31, 2022, reflecting its ongoing search for a suitable merger target during the active phase of its combination window. Focused on identifying opportunities in biopharmaceuticals, medical technology, and related healthcare subsectors, BioPlus was among the cohort of life-sciences-focused SPACs that came to market during the peak SPAC formation period. Sign up at SpacDesk for complete filing history, timeline data, and deal status on BioPlus Acquisition Corp. and hundreds of other SPACs.